Biofrontera Inc. 8-K

What Happened
Biofrontera Inc. announced preliminary, unaudited revenues for the fourth quarter and full year ended December 31, 2025 in a press release dated January 13, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K filed the same day (Item 2.02 reporting results of operations and Item 9.01 listing the exhibit).

Key Details

• Announcement date: January 13, 2026 (press release furnished as Exhibit 99.1).
• Reporting period: preliminary unaudited revenues for Q4 and full year ended December 31, 2025.
• Form filed: Current Report on Form 8-K, disclosing results of operations (Item 2.02) and including the press release as an exhibit (Item 9.01).
• The press release is incorporated by reference into the Form 8-K; no audited or final figures were included in the Form 8-K itself.

Why It Matters
Preliminary revenue disclosures give investors an early look at the company's recent sales performance ahead of audited annual results and formal quarterly filings. Because the figures are described as preliminary and unaudited, they may be revised when the company reports final audited results; investors should watch for subsequent filings (e.g., Form 10-K or subsequent 8-K) for confirmation and detail.